BROOKFIELD CORP - BNCN 4.606 PERP (BN-PR-X.CA) Stock Fundamental Analysis

TSX:BN-PR-X • CA11271J8427

19.57 CAD
-0.04 (-0.2%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BN-PR-X. BN-PR-X was compared to 82 industry peers in the Capital Markets industry. BN-PR-X has a medium profitability rating, but doesn't score so well on its financial health evaluation. BN-PR-X is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BN-PR-X had positive earnings in the past year.
  • In the past year BN-PR-X had a positive cash flow from operations.
  • BN-PR-X had positive earnings in 4 of the past 5 years.
  • Of the past 5 years BN-PR-X 4 years had a positive operating cash flow.
BN-PR-X.CA Yearly Net Income VS EBIT VS OCF VS FCFBN-PR-X.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

  • BN-PR-X has a Return On Assets (0.16%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of 1.78%, BN-PR-X is in line with its industry, outperforming 51.22% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 3.52%, BN-PR-X is doing good in the industry, outperforming 62.20% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BN-PR-X is significantly below the industry average of 10.50%.
Industry RankSector Rank
ROA 0.16%
ROE 1.78%
ROIC 3.52%
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
BN-PR-X.CA Yearly ROA, ROE, ROICBN-PR-X.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

  • BN-PR-X has a Profit Margin (1.12%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of BN-PR-X has declined.
  • BN-PR-X's Operating Margin of 26.36% is in line compared to the rest of the industry. BN-PR-X outperforms 59.76% of its industry peers.
  • BN-PR-X's Operating Margin has improved in the last couple of years.
  • BN-PR-X has a Gross Margin (37.81%) which is in line with its industry peers.
  • BN-PR-X's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.36%
PM (TTM) 1.12%
GM 37.81%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
BN-PR-X.CA Yearly Profit, Operating, Gross MarginsBN-PR-X.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • BN-PR-X has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BN-PR-X.CA Yearly Shares OutstandingBN-PR-X.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
BN-PR-X.CA Yearly Total Debt VS Total AssetsBN-PR-X.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

  • BN-PR-X has an Altman-Z score of 0.27. This is a bad value and indicates that BN-PR-X is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.27, BN-PR-X is doing worse than 71.95% of the companies in the same industry.
  • BN-PR-X has a Debt/Equity ratio of 4.62. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of BN-PR-X (4.62) is worse than 69.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.62
Debt/FCF N/A
Altman-Z 0.27
ROIC/WACCN/A
WACCN/A
BN-PR-X.CA Yearly LT Debt VS Equity VS FCFBN-PR-X.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B

2.3 Liquidity

  • BN-PR-X has a Current Ratio of 0.58. This is a bad value and indicates that BN-PR-X is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BN-PR-X has a worse Current ratio (0.58) than 62.20% of its industry peers.
  • A Quick Ratio of 0.49 indicates that BN-PR-X may have some problems paying its short term obligations.
  • The Quick ratio of BN-PR-X (0.49) is worse than 60.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.49
BN-PR-X.CA Yearly Current Assets VS Current LiabilitesBN-PR-X.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • BN-PR-X shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.03%.
EPS 1Y (TTM)-4.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.76%

3.2 Future

  • Based on estimates for the next years, BN-PR-X will show a very strong growth in Earnings Per Share. The EPS will grow by 20.80% on average per year.
  • The Revenue is expected to grow by 28.92% on average over the next years. This is a very strong growth
EPS Next Y17.95%
EPS Next 2Y20.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year44.51%
Revenue Next 2Y28.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BN-PR-X.CA Yearly Revenue VS EstimatesBN-PR-X.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
BN-PR-X.CA Yearly EPS VS EstimatesBN-PR-X.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • BN-PR-X is valuated cheaply with a Price/Earnings ratio of 5.66.
  • Based on the Price/Earnings ratio, BN-PR-X is valued a bit cheaper than 78.05% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.68, BN-PR-X is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 4.79, the valuation of BN-PR-X can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, BN-PR-X is valued cheaper than 90.24% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BN-PR-X to the average of the S&P500 Index (28.06), we can say BN-PR-X is valued rather cheaply.
Industry RankSector Rank
PE 5.66
Fwd PE 4.79
BN-PR-X.CA Price Earnings VS Forward Price EarningsBN-PR-X.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • BN-PR-X's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BN-PR-X is cheaper than 78.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.36
BN-PR-X.CA Per share dataBN-PR-X.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BN-PR-X's earnings are expected to grow with 20.80% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y20.8%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • BN-PR-X has a Yearly Dividend Yield of 5.97%, which is a nice return.
  • BN-PR-X's Dividend Yield is a higher than the industry average which is at 3.11.
  • BN-PR-X's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 5.97%

5.2 History

  • The dividend of BN-PR-X decreases each year by -3.57%.
  • BN-PR-X has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BN-PR-X has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-3.57%
Div Incr Years3
Div Non Decr Years4
BN-PR-X.CA Yearly Dividends per shareBN-PR-X.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • 84.48% of the earnings are spent on dividend by BN-PR-X. This is not a sustainable payout ratio.
DP84.48%
EPS Next 2Y20.8%
EPS Next 3YN/A
BN-PR-X.CA Yearly Income VS Free CF VS DividendBN-PR-X.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B
BN-PR-X.CA Dividend Payout.BN-PR-X.CA Dividend Payout, showing the Payout Ratio.BN-PR-X.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BROOKFIELD CORP - BNCN 4.606 PERP

TSX:BN-PR-X (2/13/2026, 7:00:00 PM)

19.57

-0.04 (-0.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners58.26%
Inst Owner ChangeN/A
Ins Owners10.25%
Ins Owner ChangeN/A
Market Cap48.47B
Revenue(TTM)N/A
Net Income(TTM)831.00M
Analysts76.84
Price Target22.36 (14.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.97%
Yearly Dividend0.4
Dividend Growth(5Y)-3.57%
DP84.48%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.61%
Min EPS beat(2)-2.36%
Max EPS beat(2)7.58%
EPS beat(4)3
Avg EPS beat(4)5.79%
Min EPS beat(4)-2.36%
Max EPS beat(4)11.75%
EPS beat(8)6
Avg EPS beat(8)13.32%
EPS beat(12)9
Avg EPS beat(12)-0.52%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1087.77%
Min Revenue beat(2)1057%
Max Revenue beat(2)1118.53%
Revenue beat(4)4
Avg Revenue beat(4)1158.06%
Min Revenue beat(4)1057%
Max Revenue beat(4)1320.03%
Revenue beat(8)8
Avg Revenue beat(8)978.41%
Revenue beat(12)12
Avg Revenue beat(12)661.57%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.14%
PT rev (3m)-1.41%
EPS NQ rev (1m)-2.83%
EPS NQ rev (3m)1.84%
EPS NY rev (1m)-0.72%
EPS NY rev (3m)0.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)6.5%
Revenue NY rev (3m)1.64%
Valuation
Industry RankSector Rank
PE 5.66
Fwd PE 4.79
P/S 0.48
P/FCF N/A
P/OCF 3.6
P/B 0.76
P/tB N/A
EV/EBITDA 9.36
EPS(TTM)3.46
EY17.68%
EPS(NY)4.08
Fwd EY20.86%
FCF(TTM)-6.17
FCFYN/A
OCF(TTM)5.44
OCFY27.81%
SpS40.91
BVpS25.66
TBVpS-20.53
PEG (NY)0.32
PEG (5Y)N/A
Graham Number44.7
Profitability
Industry RankSector Rank
ROA 0.16%
ROE 1.78%
ROCE 4.73%
ROIC 3.52%
ROICexc 3.67%
ROICexgc 4.65%
OM 26.36%
PM (TTM) 1.12%
GM 37.81%
FCFM N/A
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
ROICexc(3y)3.83%
ROICexc(5y)3.59%
ROICexgc(3y)4.77%
ROICexgc(5y)4.39%
ROCE(3y)4.96%
ROCE(5y)4.64%
ROICexgc growth 3Y2.5%
ROICexgc growth 5Y4.8%
ROICexc growth 3Y1.58%
ROICexc growth 5Y3.93%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.62
Debt/FCF N/A
Debt/EBITDA 7.26
Cap/Depr 209.1%
Cap/Sales 28.39%
Interest Coverage 250
Cash Conversion 33.32%
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.49
Altman-Z 0.27
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)209.51%
Cap/Depr(5y)213.66%
Cap/Sales(3y)20.38%
Cap/Sales(5y)19.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.49%
EPS Next Y17.95%
EPS Next 2Y20.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.76%
Revenue Next Year44.51%
Revenue Next 2Y28.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.26%
EBIT growth 3Y9.35%
EBIT growth 5Y11.02%
EBIT Next Year850.8%
EBIT Next 3Y68.63%
EBIT Next 5YN/A
FCF growth 1Y-35.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.02%
OCF growth 3Y-1.38%
OCF growth 5Y3.07%

BROOKFIELD CORP - BNCN 4.606 PERP / BN-PR-X.CA FAQ

What is the fundamental rating for BN-PR-X stock?

ChartMill assigns a fundamental rating of 3 / 10 to BN-PR-X.CA.


What is the valuation status of BROOKFIELD CORP - BNCN 4.606 PERP (BN-PR-X.CA) stock?

ChartMill assigns a valuation rating of 7 / 10 to BROOKFIELD CORP - BNCN 4.606 PERP (BN-PR-X.CA). This can be considered as Undervalued.


What is the profitability of BN-PR-X stock?

BROOKFIELD CORP - BNCN 4.606 PERP (BN-PR-X.CA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for BN-PR-X stock?

The Price/Earnings (PE) ratio for BROOKFIELD CORP - BNCN 4.606 PERP (BN-PR-X.CA) is 5.66 and the Price/Book (PB) ratio is 0.76.


How financially healthy is BROOKFIELD CORP - BNCN 4.606 PERP?

The financial health rating of BROOKFIELD CORP - BNCN 4.606 PERP (BN-PR-X.CA) is 1 / 10.